You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

relatlimab

Showing 1 - 25 of 25
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melanoma (Skin) Trial in Houston (BMS-986213 (Relatlimab-Nivolumab FDC), Nivolumab, Relatlimab)

Not yet recruiting
  • Melanoma (Skin)
  • BMS-986213 (Relatlimab-Nivolumab FDC)
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 1, 2023

Metastatic Uveal Melanoma Trial in Miami (Nivolumab, Relatlimab)

Recruiting
  • Metastatic Uveal Melanoma
  • Miami, Florida
    University of Miami Sylvester Comprehensive Cancer Center
Aug 23, 2022

Microsatellite Stable (MSS) Colorectal Adenocarcinomas, Colorectal Adenocarcinoma Trial in Baltimore (Nivolumab, Relatlimab)

Recruiting
  • Microsatellite Stable (MSS) Colorectal Adenocarcinomas
  • Colorectal Adenocarcinoma
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
Mar 14, 2022

Refractory MSI - H Solid Tumors Prior of PD-(L) 1 Therapy, MSI-H Tumors Trial in Baltimore (Nivolumab, Relatlimab)

Recruiting
  • Refractory MSI - H Solid Tumors Prior of PD-(L) 1 Therapy
  • MSI-H Tumors
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
Mar 14, 2022

Basal Cell Carcinoma Trial in Baltimore (Nivolumab, Ipilimumab, Relatlimab)

Recruiting
  • Basal Cell Carcinoma
  • Baltimore, Maryland
    Johns Hopkins Hospital
Mar 10, 2022

Hepatocellular Carcinoma Trial in Baltimore (Nivolumab, Relatlimab)

Recruiting
  • Hepatocellular Carcinoma
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
Mar 3, 2022

Head and Neck Squamous Cell Carcinoma (HNSCC) Trial in Pittsburgh (Nivolumab, Relatlimab, Ipilimumab)

Recruiting
  • Head and Neck Squamous Cell Carcinoma (HNSCC)
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Mar 31, 2022

Nasopharyngeal Carcinoma Trial (procedure, drug, biological)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • Biospecimen Collection
  • +9 more
  • (no location specified)
Sep 12, 2023

Cancer Trial in Hackensack (relatlimab, nivolumab, rHuPH20)

Active, not recruiting
  • Cancer
  • relatlimab
  • +2 more
  • Hackensack, New Jersey
    Hackensack University Medical Center
Sep 13, 2021

Melanoma Trial in Worldwide (Relatlimab, Ipilimumab)

Active, not recruiting
  • Melanoma
  • Tucson, Arizona
  • +29 more
Dec 13, 2022

Carcinomas, Renal Medullary Carcinoma Trial in Houston (Nivolumab, Relatlimab)

Not yet recruiting
  • Carcinomas
  • Renal Medullary Carcinoma
  • Houston, Texas
    MD Anderson Cancer Center
Apr 20, 2022

Acute Myeloid Leukemia Trial in Munich (Azacitidine Injection, Nivolumab, Relatlimab)

Recruiting
  • Acute Myeloid Leukemia
  • Azacitidine Injection
  • +2 more
  • Munich, Germany
    University Hospital, LMU Munich
May 30, 2021

Metastatic Melanoma, Advanced Melanoma, Metastatic Melanoma Stratified by MHC-II Expression Trial in Nashville (Nivolumab,

Terminated
Has Results
  • Metastatic Melanoma
  • +2 more
  • Nashville, Tennessee
    Vanderbilt-Ingram Cancer Center
Mar 26, 2021

Metastatic Ovarian Cancer, Metastatic Fallopian Tube Cancer, Peritoneal Cancer Trial in Herlev (Ipilimumab, Cyclophosphamid,

Recruiting
  • Metastatic Ovarian Cancer
  • +2 more
  • Herlev, Denmark
    National Center for Cancer Immune Therapy (CCIT-DK)
May 7, 2021

Advanced Cancer Trial in Worldwide (Relatlimab, Nivolumab, BMS-986205)

Recruiting
  • Advanced Cancer
  • Relatlimab
  • +3 more
  • Duarte, California
  • +23 more
Oct 24, 2022

Melanoma Trial in Worldwide (Nivolumab, Relatlimab)

Recruiting
  • Melanoma
  • Phoenix, Arizona
  • +84 more
Jan 31, 2023

Lymphoma, Non-Hodgkin, Hodgkin Disease Trial in Worldwide (Relatlimab, Nivolumab)

Not yet recruiting
  • Lymphoma, Non-Hodgkin
  • Hodgkin Disease
  • Phoenix, Arizona
  • +53 more
Aug 17, 2022

Carcinoma, Hepatocellular Trial in Worldwide (Relatlimab, Nivolumab, Bevacizumab)

Recruiting
  • Carcinoma, Hepatocellular
  • Relatlimab
  • +3 more
  • Los Angeles, California
  • +62 more
Feb 1, 2023

Cancer Trial in Kashiwa-shi (Relatlimab, Nivolumab)

Active, not recruiting
  • Cancer
  • Kashiwa-shi, Chiba, Japan
    Local Institution
Dec 3, 2021

Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular Trial in United States (JCAR017, Durvalumab,

Active, not recruiting
  • Lymphoma, Non-Hodgkin
  • +2 more
  • JCAR017
  • +7 more
  • Duarte, California
  • +17 more
Jan 13, 2023

Gastric Cancer, Adenocarcinoma of the Esophagogastric Junction Trial in Essen (Nivolumab, relatlimab, Oxaliplatin)

Recruiting
  • Gastric Cancer
  • Adenocarcinoma of the Esophagogastric Junction
  • Essen, Germany
    University Hospital Essen
May 18, 2021

NSCLC, Recurrent NSCLC, Metastatic NSCLC Trial in Worldwide (Nivolumab, Relatlimab, Carboplatin)

Recruiting
  • Non-small Cell Lung Cancer
  • +2 more
  • Nivolumab
  • +6 more
  • Arcadia, California
  • +149 more
Oct 7, 2022

Advanced Gastric Cancer Trial in Worldwide (Nivolumab, Ipilimumab, Relatlimab)

Active, not recruiting
  • Advanced Gastric Cancer
  • Nivolumab
  • +4 more
  • Phoenix, Arizona
  • +34 more
Aug 18, 2022

Advanced Cancer Trial in Worldwide (Nivolumab, Dasatinib, Relatlimab)

Terminated
Has Results
  • Advanced Cancer
  • Nivolumab
  • +4 more
  • Duarte, California
  • +49 more
Feb 23, 2021

Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +49 more
  • Birmingham, Alabama
  • +1429 more
Aug 17, 2022